 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
(ETTX-DD) Low Valuation of $84 Million / STRONG Cash of $63 Million/ 2 attractive Drugs in late Phase 3 with LARGE market potential with first readout within 6-7 months / Insider & Institutional investors holding most of the shares /Low float stock = $15-20 stock here on this undiscovered biotech gem .GL Entasis Therapeutics (ETTX) Market Cap: $84 million Cash: 63 Million Price $3.05 Shares Out: 28 million Presentation June investors.entasistx.com Major Shareholders Innoviva Inc...14M Novo Holdings A/S...2.2M AstraZeneca PLC...2.2M Clarus Ventures, LLC...1.6M Pivotal ...1.2M Sofinnova ...1.2M Frazier ...1.0M TPG Capital, L.P...1.0M Eventide Asset ...879.5K Granahan ...154.7K  
| ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |